C71T
CANCELLED SECTION 71
07/10/2026
Back to search
Official data from USPTO
BUVIDAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BUVIDAL
ST13
US500000079236518Class
5, 42, 44
Filing
79236518
Registration
5940519
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
08/04/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
05/28/2018
Registration date
12/24/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/10/2026
Last transaction
08/04/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
SE
Examiner
STEDMAN, CORI
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Camurus AB
Representatives
Karen Kreider Gaunt Dinsmore & Shohl LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsfor the treatment of substance use disorderssubstance dependencesubstance withdrawalsubstance addictionsubstance overdosefor the treatment of opiate and chemical addictionsfor the treatment of co-morbidities associated with substance use disordersfor the treatment of mental health diseases and disordersfor the treatment of central nervous system diseases and disordersfor the management and relief of pain; veterinary pharmaceutical preparationsfor the treatment of substance use disorderssubstance dependencesubstance withdrawalsubstance addictionsubstance overdosefor the treatment of opiate and chemical addictionsfor the treatment of co-morbidities associated with substance use disordersfor the treatment of mental health diseases and disordersfor the treatment of central nervous system diseases and disordersfor the management and relief of pain; sanitary preparations for medical purposes; dietetic substancesnamely dietetic beverages and dietetic sugar adapted for medical usefor the treatment of substance use disorderssubstance dependencesubstance withdrawalsubstance addictionsubstance overdosefor the treatment of opiate and chemical addictionsfor the treatment of co-morbidities associated with substance use disordersfor the treatment of mental health diseases and disordersfor the treatment of central nervous system diseases and disordersfor the management and relief of pain; plasters for medical purposesmaterials for dressingsmedical dressingsall for the treatment of substance use disorderssubstance dependencesubstance withdrawalsubstance addictionsubstance overdosefor the treatment of opiate and chemical addictionsfor the treatment of co-morbidities associated with substance use disordersfor the treatment of mental health diseases and disordersfor the treatment of central nervous system diseases and disordersfor the management and relief of pain; disinfectants; preparations for destroying vermin; fungicidesherbicides
Class 42
Scientific and technological services and researchdevelopment and design relating theretoscientific researchanalysis and testing in the field of pharmaceutical preparations and medicinesall for use in the fields of treatment of substance use disorderssubstance dependencesubstance withdrawalsubstance addictionsubstance overdosetreatment of opiate and chemical addictionstreatment of co-morbidities associated with substance use disorderstreatment of mental health diseases and disorderstreatment of central nervous system diseases and disordersmanagement and relief of pain; chemical laboratories; chemical researchchemical analysis; research in the fields of medicinesfoodscosmetics and biotechnology; development of technical know-howtechnical adviceinformationsupport and consultancy namelyscientific researchanalysis and testing in the field of pharmaceutical preparations and medicineall in the fields of the treatment of substance use disorderssubstance dependencesubstance withdrawalsubstance addictionsubstance overdosethe treatment of opiate and chemical addictionsthe treatment of co-morbidities associated with substance use disordersthe treatment of mental health diseases and disordersthe treatment of central nervous system diseases and disordersmanagement and relief of pain
Class 44
Medical services; veterinary services; consultancy relating to medicines in the nature of providing medical consultancy services
Publications
History of USPTO decisions and trademark events.
45 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
03/14/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/24/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/04/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
12/04/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/04/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/04/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/04/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/04/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/24/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/24/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/06/2020
FIMP
FINAL DISPOSITION PROCESSED
04/06/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/24/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
01/03/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
12/24/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/18/2019
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
12/18/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/08/2019
PUBO
PUBLISHED FOR OPPOSITION
10/08/2019
GPNX
NOTIFICATION PROCESSED BY IB
10/04/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/18/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/18/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/18/2019
ALIE
ASSIGNED TO LIE
09/05/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/29/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/28/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/27/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/27/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/26/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/26/2019
CNFR
FINAL REFUSAL MAILED
04/22/2019
CNFR
FINAL REFUSAL WRITTEN
04/21/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/16/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/15/2019
RFNP
REFUSAL PROCESSED BY IB
10/12/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/25/2018
RFRR
REFUSAL PROCESSED BY MPU
09/25/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/18/2018
CNRT
NON-FINAL ACTION WRITTEN
09/17/2018
DOCK
ASSIGNED TO EXAMINER
09/17/2018
MAFR
APPLICATION FILING RECEIPT MAILED
07/18/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/14/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/12/2018
Continuous trademark protection
Get notified about every new filing that threatens BUVIDAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.